Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Milestone Pharmaceuticals Inc. (MIST) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "- NDA submission for etripamil in patients with PSVT expected in October 2023 - Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with AFib-RVR"
06/09/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "Milestone Pharmaceuticals Inc."
05/11/2023 8-K Quarterly results
Docs: "- NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on Monday, May 22, 2023"
03/31/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/28/2023 8-K Quarterly results
03/27/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/07/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Q3, 2023 1 2 3"
12/06/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
10/17/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "David Pitts Argot Partners 212-600-1902"
08/10/2022 8-K Quarterly results
07/08/2022 8-K Quarterly results
03/24/2022 8-K Quarterly results
Docs: "Milestone Pharmaceuticals Inc.’s consolidated audited annual financial statements for the financial year ended December 31, 2021 and the Report of Independent Registered Public Accounting Firm thereon",
"Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update"
02/16/2022 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
Docs: "Employee Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement",
"Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer"
11/12/2021 8-K Quarterly results
Docs: "Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update",
"Joseph Oliveto President & CEO Corporate Overview November 2021"
06/21/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
03/29/2021 8-K Quarterly results
10/26/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and among the Company, Jefferies LLC and Piper Sandler & Co",
"Form of Pre-Funded Warrant",
"Opinion of Osler, Hoskin & Harcourt LLP",
"Opinion of Cooley LLP",
"Milestone Pharmaceuticals Announces Pricing of"
09/22/2020 8-K Quarterly results
07/29/2020 8-K Quarterly results
07/23/2020 8-K Quarterly results
03/23/2020 8-K Quarterly results
12/17/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Corporate Presentation"
12/03/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/13/2019 8-K Quarterly results
10/15/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/20/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/10/2019 8-K Quarterly results
08/13/2019 8-K Quarterly results
Docs: "Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results"
05/24/2019 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy